Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-ketamine for Opioid Consumption in Breast Cancer Surgery
NCT05060068Completed
- Sponsor
- The Second Affiliated Hospital of Anhui Medical University
- Start
- Oct 2021
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of esketamine in postoperative pain (3 arms), sponsored by The Second Affiliated Hospital of Anhui Medical University. Primary endpoint: Consumption of sufentanil. Started Oct 2021; status: completed.
02
Drugs
esketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05060068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05060068.